177 related articles for article (PubMed ID: 10411295)
21. Estrogen- and antiestrogen-responsiveness of HEC1A endometrial adenocarcinoma cells in culture.
Castro-Rivera E; Safe S
J Steroid Biochem Mol Biol; 1998 Mar; 64(5-6):287-95. PubMed ID: 9618030
[TBL] [Abstract][Full Text] [Related]
22. Comparative effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on MCF-7, RL95-2, and LNCaP cells: role of target steroid hormones in cellular responsiveness to CYP1A1 induction.
Jana NR; Sarkar S; Ishizuka M; Yonemoto J; Tohyama C; Sone H
Mol Cell Biol Res Commun; 2000 Sep; 4(3):174-80. PubMed ID: 11281733
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the aryl hydrocarbon receptor and aryl hydrocarbon responsiveness in human ovarian carcinoma cell lines.
Rowlands C; Krishnan V; Wang X; Santostefano M; Safe S; Miller WR; Langdon S
Cancer Res; 1993 Apr; 53(8):1802-7. PubMed ID: 8385571
[TBL] [Abstract][Full Text] [Related]
24. Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status.
Angus WG; Larsen MC; Jefcoate CR
Carcinogenesis; 1999 Jun; 20(6):947-55. PubMed ID: 10357772
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of inhibitory aryl hydrocarbon receptor-estrogen receptor crosstalk in human breast cancer cells.
Safe S; Wormke M; Samudio I
J Mammary Gland Biol Neoplasia; 2000 Jul; 5(3):295-306. PubMed ID: 14973392
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the antiestrogenic activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in human ovarian carcinoma BG-1 cells.
Rogers JM; Denison MS
Mol Pharmacol; 2002 Jun; 61(6):1393-403. PubMed ID: 12021401
[TBL] [Abstract][Full Text] [Related]
27. Molecular mechanism of inhibitory aryl hydrocarbon receptor-estrogen receptor/Sp1 cross talk in breast cancer cells.
Khan S; Barhoumi R; Burghardt R; Liu S; Kim K; Safe S
Mol Endocrinol; 2006 Sep; 20(9):2199-214. PubMed ID: 16675542
[TBL] [Abstract][Full Text] [Related]
28. The aryl hydrocarbon receptor mediates degradation of estrogen receptor alpha through activation of proteasomes.
Wormke M; Stoner M; Saville B; Walker K; Abdelrahim M; Burghardt R; Safe S
Mol Cell Biol; 2003 Mar; 23(6):1843-55. PubMed ID: 12612060
[TBL] [Abstract][Full Text] [Related]
29. Interaction of the aryl hydrocarbon receptor ligand 6-methyl-1,3,8-trichlorodibenzofuran with estrogen receptor alpha.
Pearce ST; Liu H; Radhakrishnan I; Abdelrahim M; Safe S; Jordan VC
Cancer Res; 2004 Apr; 64(8):2889-97. PubMed ID: 15087408
[TBL] [Abstract][Full Text] [Related]
30. Characterizing combined effects of antiestrogenic chemicals on vitellogenin production in rainbow trout (Oncorhynchus mykiss) hepatocytes.
Hultman MT; Petersen K; Tollefsen KE
J Toxicol Environ Health A; 2017; 80(16-18):987-1001. PubMed ID: 28849994
[TBL] [Abstract][Full Text] [Related]
31. Distinct roles for aryl hydrocarbon receptor nuclear translocator and ah receptor in estrogen-mediated signaling in human cancer cell lines.
Labrecque MP; Takhar MK; Hollingshead BD; Prefontaine GG; Perdew GH; Beischlag TV
PLoS One; 2012; 7(1):e29545. PubMed ID: 22235307
[TBL] [Abstract][Full Text] [Related]
32. The ligand status of the aromatic hydrocarbon receptor modulates transcriptional activation of BRCA-1 promoter by estrogen.
Hockings JK; Thorne PA; Kemp MQ; Morgan SS; Selmin O; Romagnolo DF
Cancer Res; 2006 Feb; 66(4):2224-32. PubMed ID: 16489025
[TBL] [Abstract][Full Text] [Related]
33. Differential activation of wild-type and variant forms of estrogen receptor alpha by synthetic and natural estrogenic compounds using a promoter containing three estrogen-responsive elements.
Yoon K; Pallaroni L; Stoner M; Gaido K; Safe S
J Steroid Biochem Mol Biol; 2001 Jul; 78(1):25-32. PubMed ID: 11530281
[TBL] [Abstract][Full Text] [Related]
34. Characterization of antiestrogenic activity of the Chinese herb, prunella vulgaris, using in vitro and in vivo (Mouse Xenograft) models.
Collins NH; Lessey EC; DuSell CD; McDonnell DP; Fowler L; Palomino WA; Illera MJ; Yu X; Mo B; Houwing AM; Lessey BA
Biol Reprod; 2009 Feb; 80(2):375-83. PubMed ID: 18923163
[TBL] [Abstract][Full Text] [Related]
35. Transcriptional activation of c-fos protooncogene by 17beta-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition.
Duan R; Porter W; Samudio I; Vyhlidal C; Kladde M; Safe S
Mol Endocrinol; 1999 Sep; 13(9):1511-21. PubMed ID: 10478842
[TBL] [Abstract][Full Text] [Related]
36. Role of estradiol receptor-alpha in differential expression of 2,3,7, 8-tetrachlorodibenzo-p-dioxin-inducible genes in the RL95-2 and KLE human endometrial cancer cell lines.
Jana NR; Sarkar S; Ishizuka M; Yonemoto J; Tohyama C; Sone H
Arch Biochem Biophys; 1999 Aug; 368(1):31-9. PubMed ID: 10415108
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells.
Spink DC; Spink BC; Cao JQ; DePasquale JA; Pentecost BT; Fasco MJ; Li Y; Sutter TR
Carcinogenesis; 1998 Feb; 19(2):291-8. PubMed ID: 9498279
[TBL] [Abstract][Full Text] [Related]
38. HES-1, a novel target gene for the aryl hydrocarbon receptor.
Thomsen JS; Kietz S; Ström A; Gustafsson JA
Mol Pharmacol; 2004 Jan; 65(1):165-71. PubMed ID: 14722248
[TBL] [Abstract][Full Text] [Related]
39. Effects of the aryl hydrocarbon receptor agonist 3-methylcholanthrene on the 17β-estradiol regulated mRNA transcriptome of the rat uterus.
Helle J; Keiler AM; Zierau O; Dörfelt P; Vollmer G; Lehmann L; Chittur SV; Tenniswood M; Welsh J; Kretzschmar G
J Steroid Biochem Mol Biol; 2017 Jul; 171():133-143. PubMed ID: 28285017
[TBL] [Abstract][Full Text] [Related]
40. Aryl hydrocarbon receptor-mediated inhibition of LNCaP prostate cancer cell growth and hormone-induced transactivation.
Morrow D; Qin C; Smith R; Safe S
J Steroid Biochem Mol Biol; 2004 Jan; 88(1):27-36. PubMed ID: 15026081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
